Back to Journals » Infection and Drug Resistance » Volume 13

Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone

Total article views   HTML views PDF downloads Totals
6,933 Dovepress* 5,673+ 906 6,579
PubMed Central* 1,260 155 1,415
Totals 6,933 1,061 7,994
*Since 22 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar